# L_2008257EN.01002501.xml

| 25.9.2008 | EN | Official Journal of the European Union | L 257/25 |
| --- | --- | --- | --- |

25.9.2008

EN

Official Journal of the European Union

L 257/25

---

DECISION OF THE EEA JOINT COMMITTEE

No 63/2008

of 6 June 2008

amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement

THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area, as amended by the Protocol adjusting the Agreement on the European Economic Area, hereinafter referred to as ‘the Agreement’, and in particular Article 98 thereof,

Whereas:

| (1) | Annex II to the Agreement was amended by Decision of the EEA Joint Committee No 47/2008 of 25 April 2008 (1). |
| --- | --- |

(1)

Annex II to the Agreement was amended by Decision of the EEA Joint Committee No 47/2008 of 25 April 2008 (1).

| (2) | Commission Regulation (EC) No 1323/2007 of 12 November 2007 amending Annex I to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, as regards firocoxib (2) is to be incorporated into the Agreement. |
| --- | --- |

(2)

Commission Regulation (EC) No 1323/2007 of 12 November 2007 amending Annex I to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, as regards firocoxib (2) is to be incorporated into the Agreement.

| (3) | Commission Regulation (EC) No 1353/2007 of 20 November 2007 amending Annex I to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, as regards Monensin, Lasalocid and Tylvalosin (3) is to be incorporated into the Agreement, |
| --- | --- |

(3)

Commission Regulation (EC) No 1353/2007 of 20 November 2007 amending Annex I to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, as regards Monensin, Lasalocid and Tylvalosin (3) is to be incorporated into the Agreement,

HAS DECIDED AS FOLLOWS:

Article 1

The following indents shall be added in point 14 (Council Regulation (EEC) No 2377/90) of Chapter XIII of Annex II to the Agreement:

| ‘— | 32007 R 1323: Commission Regulation (EC) No 1323/2007 of 12 November 2007 (OJ L 294, 13.11.2007, p. 11), |
| --- | --- |

‘—

32007 R 1323: Commission Regulation (EC) No 1323/2007 of 12 November 2007 (OJ L 294, 13.11.2007, p. 11),

| — | 32007 R 1353: Commission Regulation (EC) No 1353/2007 of 20 November 2007 (OJ L 303, 21.11.2007, p. 6).’ |
| --- | --- |

—

32007 R 1353: Commission Regulation (EC) No 1353/2007 of 20 November 2007 (OJ L 303, 21.11.2007, p. 6).’

Article 2

The texts of Regulations (EC) No 1323/2007 and (EC) No 1353/2007 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.

Article 3

This Decision shall enter into force on 7 June 2008, provided that all the notifications under Article 103(1) of the Agreement have been made to the EEA Joint Committee (*1).

Article 4

This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.

Done at Brussels, 6 June 2008.

For the EEA Joint Committee

The President

Alan SEATTER

---

(1)  
  OJ L 223, 21.8.2008, p. 42.

1

(2)  
  OJ L 294, 13.11.2007, p. 11.

2

(3)  
  OJ L 303, 21.11.2007, p. 6.

3

(*1)  No constitutional requirements indicated.

*1

---